European Psychiatry: Volume 17 - Issue S1

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 17 - Issue S1 - May 2002

S06. Substance P (NK1) receptors - possible role in stress, anxiety and affective disorders

Symposia

Pharmacology – a historical overview

Diminished anxiety- and depression-related behaviors in substance P-deficient mice

Substance P (NK1) receptors in mood disorders and schizophrenia

Clinical update: substance P antagonists in patients with major depression

NK-1 receptor antagonists: a review of preclinical and clinical data

S07. Future directions for research on fetal life and psychiatric disorders

Symposia

Obstetric complications and schizophrenia – a meta-analysis of population-based studies

How identical are monozygotic twins? An fMRI study on language lateralization

Obstetric complications and risk for first admission with schizophrenia: a Danish national register based study

Fetal growth impairment – the relevance to psychiatric outcome

Minor physical anomalies: moving to the next phase of research

PL01. Plenary Nobel Laureate Lecture: A half-century of neurotransmitter research: impact on neurology and psychiatry

Symposia

A half-century of neurotransmitter research: impact on neurology and psychiatry

LS01. Schizophrenia (Sponsored by Eli Lilly)

Symposia

Welcome and opening remarks

Neuroplasticity

Acute psychosis in clinical setting

Acute agitation: new treatments

Compliance, cognition and psychosis: first episode

Acute treatment in Eastern Europe

Quality of life and health outcomes: what really matters

LS02. Achieving success in schizophrenia: cognition, control & compliance

Symposia

Chairman’s address: Novel treatments – a promise fulfilled?

Exploring cognition and frontal lobe disorders

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 17 - Issue S1 - May 2002

S06. Substance P (NK1) receptors - possible role in stress, anxiety and affective disorders

Symposia

S07. Future directions for research on fetal life and psychiatric disorders

Symposia

PL01. Plenary Nobel Laureate Lecture: A half-century of neurotransmitter research: impact on neurology and psychiatry

Symposia

LS01. Schizophrenia (Sponsored by Eli Lilly)

Symposia

LS02. Achieving success in schizophrenia: cognition, control & compliance

Symposia